Immunome stockholders elect Siegall and Schafer as Class I directors; E&Y ratified

Immunome Inc.

Clay B. Siegall elected with 43,295,914 votes for, 80,139 withheld; broker non-votes 6,682,195.
Carol A. Schafer elected with 33,452,580 votes for, 9,923,473 withheld; broker non-votes 6,682,195.
Ratification of Ernst & Young as auditor for FY2024: 50,008,641 for, 29,664 against, 19,943 abstain; no broker non-votes.
Annual Meeting held June 12, 2024; 59,943,368 shares outstanding and entitled to vote.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.